The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

A bone-crushing side effect? The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...

Two studies examining the use of glucagon-like peptide-1 receptor agonists, including semaglutide, have found short- and long-term associations in orthopedic postoperative outcomes and general ...

While women have it more often, it’s just as dangerous for men.

A simple three-minute online assessment has been launched to help people identify their risk of osteoporosis. The Royal Osteoporosis Society’s (ROS) Great British Bone Check campaign, backed by the ...